Medicine and Dentistry
Breast Cancer
100%
Neoplasm
32%
Breast Reconstruction
22%
Hormone Receptor
21%
Breast Carcinoma
20%
Triple Negative Breast Cancer
19%
Lymph Node
15%
Gamma Urogastrone
15%
Epidermal Growth Factor Receptor 2
15%
Adjuvant Chemotherapy
15%
Chemotherapy
15%
Neoadjuvant Chemotherapy
15%
Lymph Node Metastasis
15%
Mastectomy
14%
Prognostic Factor
14%
Thyroidectomy
12%
Papillary Thyroid Cancer
12%
Overall Survival
11%
Protein P53
10%
Axillary Lymph Node
10%
Magnetic Resonance Imaging of Breast
10%
Metastatic Carcinoma
10%
Incision
10%
Retroperitoneal Lymph Node Dissection
9%
Sentinel Lymph Node
9%
Malignant Neoplasm
9%
Capsular Contracture
9%
Implant
8%
Hazard Ratio
8%
Anthracycline
8%
Magnetic Resonance Imaging
8%
Disease Free Survival
8%
Lobular Carcinoma
7%
Recurrent Disease
7%
Targeted Therapy
7%
Lymph Duct
7%
Cancer
7%
Collagen Type 1
7%
Thyroid Medullary Carcinoma
7%
Retrospective Study
7%
Factor Analysis
7%
Surgeon
6%
Breast Tumor
6%
Quality of Life
6%
Biopsy Technique
6%
Surgical Technique
6%
Quadrantectomy
6%
Metastatic Breast Cancer
6%
Postoperative Complication
5%
Disease
5%
Keyphrases
Breast Cancer
35%
Breast Cancer Patients
23%
Breast Carcinoma
17%
Triple-negative Breast Cancer
17%
Breast Cancer Cells
16%
Neoadjuvant Chemotherapy
14%
Adjuvant Chemotherapy
14%
Tumor
14%
Breast Reconstruction
11%
Clinical Prognosis
10%
Pregnancy-associated Cancer
10%
Lymph Node Ratio
10%
Papillary Thyroid Carcinoma
10%
Human Epidermal Growth Factor Receptor 2 (HER2)
10%
Breast
10%
Tumor Size
10%
Risk Factors
9%
Lymph Node Metastasis
9%
Prognostic Factors
9%
Registry Database
9%
P53 Expression
8%
Overall Survival
8%
Chemotherapy
8%
Invasive Breast Cancer
7%
Axillary Lymph Node Metastasis
7%
Anthracyclines
7%
Korean Patients
7%
Robotic Thyroidectomy
7%
Bilateral Axillo-breast Approach
7%
Myeloid-derived Suppressor Cells
7%
Fibronectin
7%
Implant Placement
7%
Clinical Subtypes
7%
Medullary Thyroid Carcinoma
7%
Disease-free Survival
7%
Matrix metalloproteinase-9 (MMP-9)
7%
Poor Prognosis
7%
Histological Grade
6%
Metastasis
6%
Patients with Breast Cancer
6%
Thyroidectomy
6%
Luminal B Subtype
6%
Ki-67
6%
Mastectomy
6%
Hazard Ratio
6%
Multivariate Analysis
5%
Phorbol 12-myristate 13-acetate
5%
Pathologic
5%
Type I Collagen
5%
Primary Breast Lymphoma
5%